BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · Real-Time Price · USD
18.03
-0.38 (-2.06%)
At close: Mar 28, 2025, 4:00 PM
18.16
+0.13 (0.74%)
After-hours: Mar 28, 2025, 4:59 PM EDT
BTSG Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for BTSG stock have an average target of 22.13, with a low estimate of 18 and a high estimate of 30. The average target predicts an increase of 22.74% from the current stock price of 18.03.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 29, 2025.
Analyst Ratings
The average analyst rating for BTSG stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 | 4 |
Buy | 3 | 4 | 5 | 5 | 5 | 4 |
Hold | 2 | 2 | 2 | 2 | 2 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 12 | 13 | 13 | 13 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Strong Buy Maintains $22 → $30 | Strong Buy | Maintains | $22 → $30 | +66.39% | Jan 29, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +10.93% | Dec 17, 2024 |
CJS Securities | CJS Securities | Buy Initiates $27 | Buy | Initiates | $27 | +49.75% | Dec 12, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | +16.47% | Dec 11, 2024 |
Wells Fargo | Wells Fargo | Buy Maintains $17 → $21 | Buy | Maintains | $17 → $21 | +16.47% | Nov 27, 2024 |
Financial Forecast
Revenue This Year
12.14B
from 11.27B
Increased by 7.77%
Revenue Next Year
13.43B
from 12.14B
Increased by 10.64%
EPS This Year
0.59
from -0.09
EPS Next Year
0.82
from 0.59
Increased by 40.00%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.0B | 14.9B | 15.1B | ||
Avg | 12.1B | 13.4B | 14.6B | ||
Low | 11.5B | 12.3B | 14.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 15.0% | 22.8% | 12.1% | ||
Avg | 7.8% | 10.6% | 8.9% | ||
Low | 2.2% | 1.3% | 4.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.79 | 1.04 | 1.26 | ||
Avg | 0.59 | 0.82 | 1.08 | ||
Low | 0.42 | 0.64 | 0.82 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 76.6% | 52.9% | ||
Avg | - | 40.0% | 30.7% | ||
Low | - | 8.2% | -0.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.